CINNARIZINE
UNII 3DI2E1X18L

Substance Identification & Data

This profile provides standardized clinical and technical data for Cinnarizine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3DI2E1X18L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 298-57-7 and the RxNorm Concept ID (RxCUI) 2549. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3DI2E1X18L

CAS Registry Number

298-57-7

RxNorm Concept ID

2549

Detailed Substance Profile

Preferred Name

CINNARIZINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C26H28N2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DERZBLKQOCDDDZ-JLHYYAGUSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C76060

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

1547484

Unique identification number in the NCBI database of chemical substances.

INN ID

1021

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1(C(c2ccccc2)c3ccccc3)CCN(CC1)C/C=C/c4ccccc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cinnarizine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.